Integrating artificial intelligence (AI) into colorectal cancer reporting

TL;DR

This paper explores how AI can improve colorectal cancer reporting and identify new prognostic indicators by analyzing histopathology data.

Contribution

The paper reviews recent advances in AI-assisted CRC reporting and AI-driven discovery of novel biomarkers.

Findings

AI tools can standardize CRC pathology reporting by extracting features from whole-slide images.

DL models outperform traditional indicators and reveal new parameters like tumor-adipocyte interactions.

Combining AI-derived indicators with standard features could improve patient outcomes.

Abstract

Artificial intelligence (AI) and deep learning (DL) are transforming cancer research and clinical care, with histopathology playing a central role in this transformation. In colorectal cancer (CRC), the second leading cause of cancer mortality world‐wide, multimodal and vision‐language models (VLMs) hold particular promise for enhancing the standardisation of histopathology reporting, the understanding of disease biology, and the discovery of novel prognostic indicators. Despite the availability of guidelines and reporting templates for essential prognostic indicators, variability remains in how key features such as TNM staging or tumour deposits are assessed and reported in routine clinical practice. AI‐based tools have the potential to support refined extraction of established and extended features directly from whole‐slide images. In parallel, recent studies have shown that DL models applied to pathology slides and associated AI‐based biomarkers can outperform traditional histopathological prognostic indicators and uncover novel parameters, including tumour‐adipocyte interactions, tumour‐stroma ratio, and immune cell patterns at the invasive margin. Here, we review recent advances in both domains: AI‐assisted standardisation of CRC pathology reporting and AI‐driven identification of novel prognostic biomarkers. We highlight the need to refine and standardise CRC reporting practices and propose that a harmonised approach combining established pathology features with AI‐derived prognostic indicators could refine risk assessment and improve outcomes for CRC patients. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Figures